Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL PK and Safety in Pectoral Plane Block for Breast Augmentation
NCT04293809Phase 1Completed
- Sponsor
- Pacira BioSciences
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of liposomal bupivacaine in postoperative pain (2 cohorts), sponsored by Pacira BioSciences. Primary endpoints: Area Under the Plasma Concentration Curve up to 96 hours, Maximum Plasma Concentration up to 96 hours and 3 more. Started Dec 2019; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04293809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04293809.